...
首页> 外文期刊>Bioorganic and medicinal chemistry >Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting
【24h】

Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting

机译:靶向核糖体的抗生素作为致癌微RNA生物发生的抑制剂:旧支架为靶向RNA的新观点

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression at the post-transcriptional level. It is now well established that the overexpression of some miRNAs (oncogenic miRNAs) is responsible for initiation and progression of human cancers and the discovery of new molecules able to interfere with their production and/or function represents one of the most important challenges of current medicinal chemistry of RNA ligands. In this work, we studied the ability of 18 different antibiotics, known as prokaryotic ribosomal RNA, to bind to oncogenic miRNA precursors (stem-loop structured pre-miRNAs) in order to inhibit miRNAs production. In vitro inhibition, binding constants, thermodynamic parameters and binding sites were investigated and highlighted that aminoglycosides and tetracyclines represent interesting pre-miRNA ligands with the ability to inhibit Dicer processing. (C) 2015 Elsevier Ltd. All rights reserved.
机译:微小RNA(miRNA)是非编码RNA,可在转录后水平调节基因表达。现已确定,某些miRNA(致癌miRNA)的过表达导致人类癌症的发生和发展,发现能够干扰其产生和/或功能的新分子的发现是当前医学领域最重要的挑战之一RNA配体的化学反应。在这项工作中,我们研究了18种不同的抗生素(称为原核生物核糖体RNA)与致癌miRNA前体(茎环结构化的pre-miRNA)结合以抑制miRNA产生的能力。在体外抑制中,研究了结合常数,热力学参数和结合位点,并着重指出氨基糖苷和四环素代表了有趣的pre-miRNA配体,具有抑制Dicer加工的能力。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号